253 related articles for article (PubMed ID: 33516601)
1. Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.
Seremba E; Ocama P; Ssekitoleko R; Mayanja-Kizza H; Adams SV; Orem J; Katabira E; Reynolds SJ; Nabatanzi R; Casper C; Phipps W
Vaccine; 2021 Feb; 39(8):1265-1271. PubMed ID: 33516601
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda.
Mayanja Y; Rida W; Kimani J; Ssetala A; Mpendo J; Nanvubya A; Mutua G; Anzala O; Price MA
PLoS One; 2023; 18(7):e0288604. PubMed ID: 37459311
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda.
Mutwa PR; Boer KR; Rusine JB; Muganga N; Tuyishimire D; Reiss P; Lange JM; Geelen SP
Pediatr Infect Dis J; 2013 Mar; 32(3):246-51. PubMed ID: 22976050
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
5. Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.
Kaech C; Pache I; Bürgisser P; Elzi L; Darling KE; Cavassini M
J Infect; 2012 Aug; 65(2):157-64. PubMed ID: 22410383
[TBL] [Abstract][Full Text] [Related]
6. Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV: A Randomized Clinical Trial.
Vargas JI; Jensen D; Martínez F; Sarmiento V; Peirano F; Acuña P; Provoste F; Bustos V; Cornejo F; Fuster A; Acuña M; Fuster F; Soto S; Estay D; Jensen W; Ahumada R; Arab JP; Soza A; Fuster F
JAMA Netw Open; 2021 Aug; 4(8):e2120929. PubMed ID: 34424307
[TBL] [Abstract][Full Text] [Related]
7. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
Seremba E; Van Geertruyden JP; Ssenyonga R; Opio CK; Kaducu JM; Sempa JB; Colebunders R; Ocama P
Vaccine; 2017 May; 35(22):2937-2942. PubMed ID: 28434689
[TBL] [Abstract][Full Text] [Related]
8. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
[TBL] [Abstract][Full Text] [Related]
9. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
10. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
[TBL] [Abstract][Full Text] [Related]
11. Association between hepatitis B vaccine antibody response and CD4 reconstitution after initiation of combination antiretroviral therapy in HIV-infected persons.
Allen K; Mesner O; Ganesan A; O'Bryan TA; Deiss RG; Agan BK; Okulicz JF
BMC Infect Dis; 2015 May; 15():203. PubMed ID: 25928043
[TBL] [Abstract][Full Text] [Related]
12. Persistence of Hepatitis B Immunity Following 3-dose Infant Primary Series in HIV-infected Thai Adolescents and Immunologic Response to Revaccination.
Lapphra K; Angkhananukit P; Saihongthong S; Phongsamart W; Wittawatmongkol O; Rungmaitree S; Chokephaibulkit K
Pediatr Infect Dis J; 2017 Sep; 36(9):863-868. PubMed ID: 28419007
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand.
Chonwattana W; Raengsakulrach B; Holtz TH; Wasinrapee P; Tongtoyai J; Chaikummao S; Pattanasin S; McNicholl JM; van Griensven F; Curlin ME
Vaccine; 2016 Apr; 34(17):2044-50. PubMed ID: 26685092
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
Lao-Araya M; Puthanakit T; Aurpibul L; Taecharoenkul S; Sirisanthana T; Sirisanthana V
Vaccine; 2011 May; 29(23):3977-81. PubMed ID: 21473954
[TBL] [Abstract][Full Text] [Related]
15. Long-term protection after hepatitis B vaccination in people living with HIV.
Lara AN; Sartori AM; Fonseca MO; Lopes MH
Vaccine; 2017 Jul; 35(33):4155-4161. PubMed ID: 28669615
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody.
Laksananun N; Praparattanapan J; Kotarathititum W; Supparatpinyo K; Chaiwarith R
AIDS Res Ther; 2019 May; 16(1):10. PubMed ID: 31053142
[TBL] [Abstract][Full Text] [Related]
17. Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study.
Piroth L; Launay O; Michel ML; Bourredjem A; Miailhes P; Ajana F; Chirouze C; Zucman D; Wendling MJ; Nazzal D; Carrat F; Rey D; Binquet C;
J Infect Dis; 2016 Jun; 213(11):1735-42. PubMed ID: 26768256
[TBL] [Abstract][Full Text] [Related]
18. Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya.
Irungu E; Mugo N; Ngure K; Njuguna R; Celum C; Farquhar C; Dhanireddy S; Baeten JM
J Infect Dis; 2013 Feb; 207(3):402-10. PubMed ID: 23175769
[TBL] [Abstract][Full Text] [Related]
19. [Are teenagers immunized in infancy still protected against hepatitis B?].
Pokorska-Lis M; Marczyńska M
Przegl Lek; 2010; 67(1):13-7. PubMed ID: 20509565
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.
Landrum ML; Hullsiek KH; Ganesan A; Weintrob AC; Crum-Cianflone NF; Barthel RV; O'Connell RJ; Fieberg A; Chun HM; Marconi VC; Dolan MJ; Agan BK;
AIDS; 2010 Feb; 24(4):545-55. PubMed ID: 19487908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]